PolyPeptide Group AG (PPGN) CHF0.01
- Add to watchlist
- This stock can be held in a
Business summary
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Contact details
Important dates
General stock information
- Short code:
- PPGN
- ISIN:
- CH1110760852
- Market cap:
- 958.90 million CHF
- Shares in issue:
- 32.98 million
- Sector:
- Life Sciences Tools & Services
- Exchange:
- SIX Swiss Exchange
- Country:
- Switzerland
- Currency:
- Swiss Franc
- Indices:
- Swiss All Share Index
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.